scispace - formally typeset
X

Ximei Qian

Researcher at Emory University

Publications -  35
Citations -  4191

Ximei Qian is an academic researcher from Emory University. The author has contributed to research in topics: Photoionization & Ionization energy. The author has an hindex of 20, co-authored 35 publications receiving 3844 citations. Previous affiliations of Ximei Qian include Tsinghua University & Georgia Institute of Technology.

Papers
More filters
Journal ArticleDOI

Single-molecule and single-nanoparticle SERS: from fundamental mechanisms to biomedical applications

TL;DR: A new class of colloidal metal nanoparticles that is able to enhance the efficiencies of surface-enhanced Raman scattering (SERS) by as much as 10(14)-10(15) fold is discussed, which allows spectroscopic detection and identification of single molecules located on the nanoparticle surface or at the junction of two particles under ambient conditions.
Journal ArticleDOI

SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging.

TL;DR: Spectroscopic Tagging helps clarify the role of X-ray diffraction in the determination of Higgs boson levels in the response of EMTs to injury.
Journal ArticleDOI

On the Enthalpy of Formation of Hydroxyl Radical and Gas-Phase Bond Dissociation Energies of Water and Hydroxyl

TL;DR: In this paper, a consensus value of the appearance energy of the O−H bond energy was derived from a mass-selected photoionization measurements, pulsed-field-ionization photoelectron spectroscopy measurements, and photo-electron-photoion coincidence measurements.
Journal ArticleDOI

Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy

TL;DR: This work states that IO nanoparticles possess unique paramagnetic properties, which and generate significant susceptibility effects resulting in strong T2 and T2* contrast, as well as T1 effects at very low concentrations for magnetic resonance imaging (MRI), which is widely used for clinical oncology imaging.
Journal ArticleDOI

Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.

TL;DR: SERS nanoparticles with epidermal growth factor peptide as a targeting ligand have successfully identified CTCs in the peripheral blood of 19 patients with squamous cell carcinoma of the head and neck (SCCHN) and may provide an important new clinical tool for management of patients with SCCHN and other cancers.